ReviewMicrobial cell factories2025
Microalgae-based bioremediation of refractory pollutants: an approach towards environmental sustainability.
Review in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Microbial Metabolic Strategies for Environmental Detoxification: From Enzymatic Mechanisms to Synthetic Biology and Omics.Applied biochemistry and biotechnology · 2026Review
- Integrated Phytoremediation of Microplastics and Sustainable Biofuel Production Using Spirulina (Arthrospira) Platensis: A Case Study of the Ergene River in Türkiye.Water environment research : a research publication of the Water Environment Federation · 2026Article
- Sustainable dye removal from industrial wastewater using marine algae-derived biosorbents and MOF-based hybrid composites.Scientific reports · 2026Article
- A TODIM based decision-making framework using intuitionistic double hierarchy linguistic terms for evaluating polymer absorbing algae in marine debris management.Scientific reports · 2026Article
- Revolutionizing bio-hydrogen production: smart integration of nanotechnology, microbial engineering, and circular waste valorisation.Bioresources and bioprocessing · 2026Review
- CRISPR-Cas Technology TurnsMarine drugs · 2025Review
- Algal-based membrane bioreactors: a sustainable Frontier for removing emerging pollutants from wastewater.RSC advances · 2025Review
- A solar panel-origin microalga, Coelastrella thermophila D14, with high potential for wastewater biotechnology.Applied microbiology and biotechnology · 2025Article
- Microalgae-based bioremediation of emerging contaminants: techniques, recent developments, and future perspectives.Archives of microbiology · 2025Review
- Phyto-Algal Consortia as a Complementary System for Wastewater Treatment and Biorefinery.Plants (Basel, Switzerland) · 2025Review
- Microbial Nanoparticles in Biological Plant Protection.International journal of molecular sciences · 2025Review
- Microalgae biotechnology and its role in sustainable and healthy food design.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extensive anthropogenic activity has led to the accumulation of organic and inorganic contaminants in diverse ecosystems, which presents significant challenges for the environment and its inhabitants. Utilizing microalgae as a bioremediation tool can present a potential solution to these challenges. Microalgae have gained significant attention as a promising biotechnological solution for detoxifying environmental pollutants. This is due to their advantages, such as rapid growth rate, cost-effectiveness, high oil-rich biomass production, and ease of implementation. Moreover, microalgae-based remediation is more environmentally sustainable for not generating additional waste sludge, capturing atmospheric CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.